WUMO confirms the molecular identity of each research peptide batch by ESI-TOF mass spectrometry — a method that checks whether the material actually is the compound named on the label. Identity is a different question from purity or content: mass spectrometry answers “is this the right molecule?”, while HPLC purity and assay answer “how clean is it” and “how much is in the vial”. All material is supplied for research and laboratory use only.

What mass spectrometry actually confirms

A mass spectrometer measures the mass-to-charge ratio of ionised molecules. For a peptide, the observed mass should match the theoretical molecular weight calculated from its sequence. When it does, the result supports the conclusion that the batch contains the intended peptide rather than a different sequence, a truncated fragment, or an unrelated compound.

This is an identity check. It is not a purity percentage and not a content (assay) figure. A batch can return a clean identity result and still need a separate HPLC purity report and, where relevant, a content or counter-ion assay before a purchasing decision. Buyers reviewing a full documentation package can see how these layers fit together in the COA, HPLC and LC-MS documentation review guide.

How an MS identity result is read

Under electrospray ionisation (ESI), peptides commonly pick up more than one charge. A larger peptide will appear at several mass-to-charge values at once — for example a doubly, triply, or quadruply charged form — and each charge state can be converted back to the same underlying molecular weight. Smaller peptides may appear mainly as a singly charged ion. Reading an MS identity result therefore means:

  • Identifying the charge state of each major peak.
  • Converting the observed mass-to-charge values back to the neutral molecular weight.
  • Comparing that deconvoluted weight against the theoretical molecular weight for the sequence.

For metal-complex peptides such as Copper Tripeptide-1, the spectrum also carries a characteristic isotope signature from the metal, which is a useful additional confirmation that the complex is present rather than the free peptide alone. The distinction between identity, purity and content for a copper peptide is covered in GHK-Cu copper content vs purity.

A worked example

The arithmetic is worth seeing once, because it is what separates a report a buyer can check from a report a buyer has to trust. Take a batch of SS-31, molecular weight 639.79. Its spectrum showed a peak at 640.72 and another at 320.93. The first is the molecule carrying one proton, so subtracting that proton returns 639.71. The second carries two protons across a mass-to-charge axis, so multiplying by two and subtracting two protons returns 639.85. Two peaks, measured independently, converging on the same weight.

A smaller peptide behaves differently again. A batch of KPV, molecular weight 342.43, showed peaks at 343.37, 685.90 and 707.87: the protonated molecule, two molecules held together by a shared proton, and that same pair carrying a sodium ion instead. Three different ion forms, all consistent with one molecular weight. This is why a spectrum with several labelled peaks is not a sign of an impure sample — it is often the opposite, because a coincidental match at three separate mass values is far less likely than a coincidental match at one.

Confirming identity a second way: reference-standard co-elution

Mass spectrometry is not the only way to ask whether a batch is the intended compound, and it is not always sufficient on its own. Two different molecules can share a molecular weight. A second, independent check is to run the batch against a purchased reference standard of the same compound under identical chromatographic conditions and compare retention times. If the two elute at effectively the same point with comparable peak shape, the batch behaves chromatographically like the reference material.

On a recent Retatrutide batch, the sample eluted at 13.667 minutes against a reference standard at 13.740 minutes. Taken alone that is suggestive rather than conclusive — co-elution is evidence of consistency, not proof of structure. Taken together with a mass spectrometry result, it is materially stronger than either, because the two methods interrogate different physical properties: how a molecule partitions on a column, and what it weighs. Reference standards are not cheap, which is one reason they are uncommon in commodity peptide documentation, and one reason a supplier that has bought one is usually worth asking about it.

Reading the report, not just the number

A purity or identity figure is only as good as the document carrying it, and a document can be internally inconsistent in ways that are visible to anyone who looks. Three checks cost a reviewer very little and catch most of what goes wrong:

  • Does the stated date match the data? Chromatography and MS software stamps the raw data file name onto the printout, usually in a corner of the chart, and that name almost always encodes the acquisition date. If the header says one date and the embedded file name implies another, the document has been assembled rather than generated, and the figures may belong to a different lot entirely.
  • Is there a batch number, and does it appear on every page? A purity figure not tied to an identifiable lot cannot be matched to the material in the box. This is the single most common gap in peptide documentation.
  • Does the instrument agree with the table? Mass spectrometry software prints its own calculated molecular weight alongside the spectrum. If that calculated value disagrees with the molecular weight typed into the summary table, one of the two is wrong, and it is worth asking which before relying on either.

A related point applies to purity: a chromatogram will normally contain peaks that are not sample at all — the solvent front at the start of the run, and a disturbance where the gradient returns to starting conditions at the end. Excluding those from the calculation is correct and routine, but it should be demonstrable. Asking for the blank solvent injection alongside the sample chromatogram lets a reviewer confirm that the excluded peaks appear in the blank too, which turns a judgement call into something checkable.

None of this requires a chemistry background. It requires reading the document as a document.

Identity confirmation, batch by batch

WUMO runs ESI-TOF identity confirmation on research peptide batches rather than relying on a single historical result reused across lots. Because identity is the first thing a downstream laboratory needs to trust, confirming it per batch keeps the record aligned with the material a buyer actually receives.

Buyers can request the identity record tied to a specific batch as part of the documentation package. Independent third-party verification can also be arranged where authorised; identity confirmation by the supplier and verification by an external laboratory answer the same question from two sides and are most useful together.

Where identity sits in the full review

Identity confirmation is the entry point, not the whole picture. A complete research peptide review usually pairs it with:

  • HPLC purity for the same batch.
  • Content or assay figures where the buyer’s work depends on them.
  • Batch number, manufacturing and retest dates, storage and packaging details.
  • SDS and a specification sheet.

Keeping identity, purity and content as separate, batch-linked data points — rather than a single blended “99%” claim — is what lets a purchasing team compare quotes on documentation, not just price.

Research peptides confirmed this way

Identity confirmation by ESI-TOF MS applies across WUMO’s research peptide raw materials, including projects such as Retatrutide, Semaglutide, BPC-157, MOTS-c, SS-31, KPV, Copper Tripeptide-1 (GHK-Cu), and shorter research peptides such as DSIP, Kisspeptin-10 and Selank. All are offered as raw material for research and laboratory use only. To request the batch documentation package or a quotation, use the documentation and RFQ request form, or review the document center.

Frequently Asked Questions

What does mass spectrometry confirm for a peptide?

It confirms identity — whether the measured molecular weight matches the theoretical weight for the intended sequence. It indicates the material is the right molecule, but it does not by itself report purity or how much peptide is in the vial.

Is an MS identity result the same as purity?

No. Identity (mass spectrometry) and purity (typically HPLC) are different measurements that answer different questions. A batch should have both reviewed, tied to the same batch number.

Why are there several peaks for one peptide?

Under electrospray ionisation a peptide often carries multiple charges, so it appears at several mass-to-charge values at once. Each charge state converts back to the same molecular weight, which is how the identity is confirmed.

Can I get the MS identity record for my specific batch?

Yes. The identity record can be provided as part of the batch documentation package. Independent third-party verification can also be arranged where authorised.

Why does a small peptide show peaks at twice its molecular weight?

Small peptides commonly form ion pairs in the source, so a spectrum may show two molecules sharing a proton, or that pair carrying a sodium ion, alongside the singly protonated molecule. These are ion forms of the same compound, not impurities, and each converts back to the same molecular weight.

How can I tell whether an analytical report is tied to the batch I am buying?

Look for a batch number that appears on the report itself, and check that the stated acquisition date is consistent with the raw data file name printed on the chart. A report without a batch identifier cannot be matched to the material delivered, whatever figure it carries.

Does supplier identity confirmation replace third-party testing?

They complement each other. Supplier-side identity confirmation and independent verification answer the same question from two directions; serious buyers generally value having both.